We analyzed acetyicholinesterase (AcChoEase; EC 3.1.1.7) activity and AcChoEase immunoreactive protein in chicken brain by using five monoclonal antibodies raised against chicken AcChoEase. Four of them specifically recognized AcChoEase catalytic subunits in Western blots and one, C-131, recognized only enzymaticafly active AcChoEase. We observed considerable differences in the ratio of immunoreactive protein to catalytic activity in various fractions, indicating the existence of inactive AcChoEase protein. This inactive AcChoEase component was more abundant in a low-saltsoluble extract than in a subsequent detergent-soluble extract. On the basis of the ratio between activity and immunoreactivity, we calculated that the inactive component represents about 30% of the total AcChoEase subunits in chicken brain. The immunoreactive AcChoEase protein sedimented in sucrose gradients like the active molecular forms; the G1 and G2 peaks contained inactive molecules, whereas the G4 peak appeared to contain only active AcChoEase. The bulk of inactive AcChoEase reacted with the organophosphate cholinesterase inhibitor O-ethyl S-[2-(diisopropylamino)ethylJmethylphosphonothioate (MTP) but was found to bind the active site affinity ligand N-methylacridinium poorly and was not recognized by the active-form-specific monoclonal antibody, C-131. In addition, most of this fraction is sensitive to endoglycosidase H and binds the lectin wheat germ agglutinin poorly, suggesting that it was not processed in the Golgi apparatus. From these observations, we propose that the active and inactive AcChoEase components are differently folded.
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Acetylcholinesterase (AcChoEase; EC 3.1.1.7) presents a panoply of molecular forms consisting of monomers (Ga), homo-oligomers (dimers, G2, and tetramers, G4), and heterooligomers which incorporate structural as well as catalytic subunits (collagen-tailed or asymmetric forms and hydrophobic-tailed tetramers) (for review, see ref. 1) . The catalytic subunits of all forms of AcChoEase are encoded by a single gene. In the case of chicken, this was demonstrated by Rotundo et al. (2) , by an analysis of two allelic forms, a and A, differing by their mass in sodium dodecyl sulfate/ polyacrylamide gel electrophoresis.
AcChoEase plays a key role in cholinergic transmission, but it also occurs in noncholinergic contexts. In vertebrates, both cholinesterases, AcChoEase and butyrylcholinesterase, are expressed very early during development, before the establishment of synapses. The cholinesterases are thought to be involved in cellular differentiation and in morphogenetic mechanisms (3) and possibly in cellular interactions in the adult (4) . It is intriguing that cholinesterases may participate in such interactions independently of their catalytic activity (5).
The catalytic activity of newly synthesized AcChoEase is first detected in the rough endoplasmic reticulum, as shown by histochemical studies-e.g., in chick muscle cultures (6) . AcChoEase is, however, synthesized as an inactive precursor, as shown by an analysis of the kinetics of production of labeled active molecules, after metabolic incorporation of heavy isotopes, in T28 murine neuroblastoma cells (7); the catalytic activity is acquired only after a lag period of about 30 min. The existence of inactive AcChoEase subunits was directly demonstrated by radioactive metabolic labeling of primary cultures of chick myotubes (8, 9) . In this case, it was found that a large majority of AcChoEase subunits never acquired catalytic activity but were degraded rapidly in a nonlysosomal compartment. Distinct inactive AcChoEase subunits were also described in Torpedo electric organs (10) .
Considering the quantitative importance ofthe synthesis of inactive AcChoEase protein in culture and the possibility that such inactive molecules may be endowed with structural functions, we decided to explore the existence of inactive AcChoEase in vivo. A comparison ofthe AcChoEase activity of various fractions of chick brain with their immunoreactivity, using monoclonal antibodies raised against chicken AcChoEase, indicated the presence of an important pool of inactive AcChoEase protein, and we report some of its solubilization, sedimentation, and binding properties.
MATERIALS AND METHODS
Materials. The N-methylacridinium affinity ligand was synthesized as described (11, 12) (14) . AcChoEase forms were analyzed in sucrose gradients, in the presence of 1% Triton X-100, as described (15 Purification of AcChoEase and Preparation of Monoclonal Antibodies. AcChoEase was purified from chicken brains by affinity chromatography (12, 16) . Monoclonal antibodies were prepared as described for Torpedo and Electrophorus AcChoEase (17) . Hybridoma clones were selected for the production of antibodies which bound chicken AcChoEase activity by using a solid-phase enzyme immunoassay (J.-M.C., F.-M.V., J.M., and J.G., unpublished results). Five monoclonal antibodies against chicken AcChoEase-e.g., C-6 and C-54-were used in the present study, as ascites fluids. The antibodies C-6, C-54, and C-131 were isolated from ascites fluids by chromatography on staphylococcal protein A-Sepharose.
Radioimmunoassay of AcChoEase Protein. AcChoEase immunoreactive protein was quantified by a two-site radioimmunoassay, similar to that used previously by Brimijoin et al. (18) for rat AcChoEase. The purified monoclonal antibodies C-6 or C-131 were adsorbed to the walls of plastic tubes, and the second antibody, 125I-labeled C-54, was used at saturating concentration. The method will be described in greater detail elsewhere (J.-M.C., F.-M.V., J.M., and J.G., unpublished results). All the experiments shown in the figures were performed with the same extract and with the same 125I-labeled monoclonal antibody, C-54, so that the specific radioactivity is the same in all cases.
Titration of Active Sites with O-Ethyl S-[2-(diisopropylamino)ethyl]methylphosphonothioate (MTP). The organophosphate cholinesterase inhibitor MTP was used for titrating active sites, as described previously (19) . To separate AcChoEase from other cellular proteins that might react with this compound, a sample of brain extract containing 30 milliunits (mU) of activity was diluted to 200 ,ul in 50 mM potassium phosphate, pH 7/400 mM NaCl/0.1% Triton X-100 containing bovine serum albumin at 0.1 mg/ml and 0.05% sodium azide and adsorbed overnight on immobilized C-6 monoclonal antibody, as in the first steps of the radioimmunoassay. After being washed with 50 mM potassium phosphate, pH 7/0.1% Nonidet P-40, the samples were incubated overnight at 4°C with MTP in 50 mM potassium phosphate, pH 7/400 mM NaCl containing bovine serum albumin at 0.1 mg/ml and 0.05% sodium azide. The tubes were washed and residual AcChoEase activity was determined.
Binding to WGA-Sepharose. A total detergent extract was adsorbed in batch overnight with WGA-Sepharose (Sigma); typically, we used 100 A.l of gel for 700 ,ul of extract, containing 7 Ellman units (16) of AcChoEase. The gel was then washed twice with 10 vol (1 ml) of 200 mM NaCl/0.1% Nonidet P-40/50 mM MgCl2/50 mM Tris HCI, pH 7. AcChoEase was then eluted with 5 vol of 500 mM N-acetyl-Dglucosamine/0.1% Triton X-100/50 mM MgCl2/50 mM Tris HCl, pH 7.
RESULTS
AcChoEase Activity and Immunoreactivity: Existence of Inactive AcChoEase Protein. We analyzed the immunoreactive AcChoEase protein in LSS and DS fractions of 1-day-old chick brain, by Western blotting. As shown in Fig. 1B , the staining intensity of the 100-to 110-kDa band was markedly more intense in the LSS than in the DS fraction for samples containing equivalent AcChoEase activities (30 mU). This cannot be due to a non-AcChoEase contaminant, which would comigrate with AcChoEase and possess a crossreacting epitope, since we obtained similar results with each of the five selected monoclonal antibodies recognizing distinct epitopes.
We used the same activity of LSS and DS extracts in a two-site radioimmunoassay with either C-6 or C-131 as the immobilized monoclonal antibodies. In the case of C-131, the bound label is proportional to the activity and does not Samples of LSS and DS extracts containing the same AcChoEase activity were denatured, reduced, and submitted to sodium dodecyl sulfate/polyacrylamide gel electrophoresis. Western blots were stained with a mixture offive distinct monoclonal antibodies, specific for chicken AcChoEase. The LSS extract contains more immunoreactive material than the DS extract does.
depend on the type of extract (Fig. 1A) , suggesting that this antibody reacts specifically with active AcChoEase. In the case of C-6, however, we observe a difference in the ratio of AcChoEase immunolabeling to AcChoEase activity.
Both experiments thus reveal the presence of a higher proportion of AcChoEase protein in the LSS fraction than in the DS fraction, compared with catalytic activity. It is extremely unlikely that the catalytic turnover of LSS AcChoEase in general would be different from that of DS AcChoEase, since their properties are otherwise identical. These observations therefore suggest the existence of a distinct compartment of inactive, or very poorly active, AcChoEase molecules. Sedimentation of Active and Inactive AcChoEase. In chicken brain, AcChoEase exists as monomers (Ga), dimers (G2), and tetramers (G4) (20) . A total detergent extract (containing LSS and DS fractions) from newly hatched chicken brain was analyzed by sucrose gradient centrifugation in the presence of Triton X-100 (Fig. 2) . Each fraction was analyzed by Western blotting (not shown) and was adsorbed on C-131 and on C-6; the bound AcChoEase was assayed for catalytic activity and immunoreactivity with labeled C-54. The immunoreactive protein was distributed under distinct peaks, which coincided with those of AcChoEase activity. These results indicated that the interactions of active and inactive molecules with detergent were similar. Fig. 2B shows that there is a perfect proportionality between the activity and immunoreactivity profiles ofAcChoEase adsorbed on C-131, in agreement with the specificity of this antibody for active AcChoEase. This is not the case, however, with the monoclonal antibody C-6, which recognized both active and inactive AcChoEase; using the same scales for activity and immunoreactivity, we observed an excess of immunoreactive material cosedimenting principally with the G2 and G1 forms (Fig. 2A) . Neurobiology: Chatel et Fig. 2A we estimated the proportion of active and inact molecules. We first determined the yield with which each the molecular forms bound to the immobilized antibody, C by comparing the activities of the fractions correspondinf each form in a gradient run with the original extract ( shown), and after binding to the antibody (Fig. 2A) . We ti found that the antibody retained 75% of G4, 70% of G2, E 40% of G1 in these experimental conditions. The influence the polymeric state on binding is an expected and reprod ible feature. We assume that the yield of binding is identi for inactive and active oligomers and that they are recogni; equally well by labeled antibody C-54.
The ratio of enzyme activity to radioactivity is identical the G1, G2, and G4 forms after binding to the C-131 antib( (Fig. 2B) , which is thought to retain only active molecu] We conclude that the polymeric forms do not combine act and inactive catalytic subunits. In addition, we obtained same ratio of enzyme activity to radioactivity when the form was bound to the C-6 antibody, which retains b active and inactive molecules. It follows that the G4 fc consists exclusively of active molecules. Dividing the zyme activity to radioactivity ratio of the G1 and G2 forms that of G4, we therefore obtain the proportion of act subunits relative to total subunits for these forms.
We can thus calculate that the G2 peak contains 2/3 act subunits and 1/3 inactive subunits and that the G1 p contains 1/3 active subunits and 2/3 inactive subunits. ON all, considering that the activity of the extract corresponds to 72% G4, 14% G2, and 14% G1, as determined from the sedimentation profile of the total activity (not shown), we estimate that the inactive subunits represent about 30% of the total. It is important to note that, because of the unequal binding of the different forms, activity-to-radioactivity ratios for preparations containing several molecular forms cannot give a correct estimate of the proportion of inactive subunits.
Different Glycosylation of Inactive and Active AcChoEase Molecules. Digestion with endoglycosidase H and N-glycanase. As shown in Fig. 3 , all forms were deglycosylated by N-glycanase; in Western blots, the deglycosylated subunits appeared as doublets, probably corresponding to the a and f8 allelic variants. The G4 component was essentially resistant to endoglycosidase H, while the bulk of the G2 and G1 fractions was sensitive to this enzyme. The deglycosylated polypeptides migrate at exactly the same position in the case of the G4 form, which contains only active molecules, and in the case of the G2 and G1 forms, which contain a significant proportion of inactive molecules. The polypeptides of active and inactive molecules thus appear identical. Binding to WGA-Sepharose. Most of the activity is retained on WGA (only 15% is not bound), and about 40% is recovered in the specifically eluted fraction (Fig. 4) . The ratio of AcChoEase activity to AcChoEase immunoreactive protein was considerably higher in the WGA-binding fraction (WGA+) than in the nonretained fraction (WGA-). WGAfractions were analyzed by sucrose gradients, and the profile of activity and immunoreactivity retained on C-6 is shown in Fig. 5 .
The AcChoEase activity retained on WGA-Sepharose corresponds mostly to the G4 molecular form (not shown inactive molecules from WGA+ and WGA-were specifically adsorbed on immobilized C-6 monoclonal antibody and incubated overnight with variable concentrations of MTP. After inhibition, the remaining activity was plotted as a function of the amount of inhibitor (Fig. 6) . If all MTPreactive sites were of equal activity, the slopes obtained with the WGA+ and WGA-samples would be parallel. Instead, inhibition of a WGA-sample requires a 2.7-fold higher amount of MTP than a WGA+ sample containing the same activity, indicating that the inhibitor is reacting with sites of reduced or zero activity in the WGA-sample.
DISCUSSION
In the present study, we used several monoclonal antibodies specific for chicken AcChoEase, so as to analyze AcChoEase immunoreactive protein in chicken brain by Western blotting and by a two-site radioimmunoassay. We found that the ratio of AcChoEase immunoreactivity to AcChoEase activity differs markedly in LSS and DS fractions, suggesting the presence of inactive AcChoEase. This was confirmed by the fact that the lectin WGA retained a much higher proportion of activity than of immunoreactive protein.
We estimate inactive AcChoEase subunits to account for -30% of the total AcChoEase subunits in chicken brain. We have obtained similar data demonstrating that chicken muscle also contains inactive AcChoEase protein together with active AcChoEase, while liver contains neither active nor inactive AcChoEase protein (J.-M.C., F.-M.V., J.M., and J.G., unpublished results).
Inactive AcChoEase molecules contain polypeptides which comigrate with the active AcChoEase subunit at 100-110 kDa in sodium dodecyl sulfate/polyacrylamide gel electrophoresis after deglycosylation. In the native state, the inactive molecules appear very similar to the active ones, since they react with the active serine organophosphate reagent MTP and sediment like the active G1 and G2 forms in the presence of Triton X-100 or Brij-96 (J.-M.C., F.-M.V., J.M., and J.G., unpublished results). Active and inactive subunits do not seem to form mixed dimers, and inactive subunits are not incorporated into tetramers. Inactive subunits obviously differ from active subunits in the conformation of the catalytic site and by their lower affinity for the active-site ligand N-methylacridinium. The fact that they react with MTP suggests that inactive molecules possess some catalytic activity, with a slower turnover than regular AcChoEase. It is noteworthy that inactive molecules are not recognized by the monoclonal antibody C-131, which appears to be conformation dependent, since its binding is lost together with activity during heat denaturation (24 cosidase H suggests that they are localized in the endoplasmic reticulum. Rotundo et al. (9) reported that in chick muscle cultures most of the newly synthesized AcChoEase polypeptides are inactive, sensitive to endoglycosidase H, do not bind WGA, and are rapidly degraded in a nonlysosomal compartment. These inactive molecules correspond to the G, and G2 forms, like the inactive molecules observed in the present study. The relationship between the inactive AcChoEase pool described here and the inactive molecules observed by Rotundo et al. remains to be established.
We suggest that the inactive AcChoEase molecules, since they closely resemble the catalytically active molecules, represent the result of an alternative folding process, as opposed to randomly malfolded protein which would form ill-defined aggregates. The existence of intracellular inactive AcChoEase seems to be the first example of a significant proportion of an alternatively folded enzyme occunring in vivo, in normal physiological conditions. An inactive form of monomeric AcChoEase, which did not bind the active-site ligand edrophonium, was previously described in Torpedo electric organ (10) . In contrast, Brimijoin and colleagues, using a two-site radio-immunoassay, did not find evidence for inactive AcChoEase in rat (18) and human (21) tissues under various physiological conditions.
It may be relevant that, at the endplates of mouse sternomastoid and diaphragm muscles, about 30%o of the diisopropyl fluorophosphate-reactive AcChoEase-like sites did not correspond to active AcChoEase (22) . In fast-twitch muscles of mature chickens, a comparison of labeling and microdetermination of activity also suggested that 10-20% of the sites were inactive but sensitive to eserine (23) . It is, therefore, possible that a minor fraction of the inactive AcChoEase molecules reach the plasma membrane. If this is indeed the case, inactive AcChoEase molecules might be involved in structural interactions at neuromuscular endplates. The significance of the presence of inactive AcChoEase molecules in vivo remains, however, entirely hypothetical.
